January 25th, 2011

The State of the Business Address

Every January, following the release of the company’s fourth-quarter 2010 earnings, our chairman and chief addresses the financial analysts who follow the company to provide an assessment of the state of the business.  Earlier today, Chairman and CEO Bill Weldon did just that.  You can listen to a replay of the earnings call – including Bill’s remarks – but I thought it would be of interest to share a few things covered during this wide-ranging discussion for those checking out JNJBTW.  As he finished the call, Bill made the following points:

“Whether we encounter periods of slow economic growth, a product issue, or a market challenge, this commitment [to Our Credo Operating Model and our people] is the reason we can manage through the turbulent times, continue investing, and stay well-positioned for sustainable growth.

As I wrap-up, let me re-cap some of the critical points I hope you will take away today.

Johnson & Johnson is built on a strong foundation, driven by its Credo and operating model, and we are emerging stronger from recent challenges.

Our overall business is performing well, led by our Medical Devices & Diagnostics and Pharmaceuticals businesses.

We have made changes to address our supply chain issues and continue to build the Consumer business with science-based innovations that will lead the market as the business and economy recovers.

Read More

January 12th, 2011

J&J Units Veridex and Ortho Biotech R&D Collaborate on the Future of Cancer Diagnostics

From Devon Prutzman, Director, Worldwide Communications, Ortho-Clinical Diagnostics

On Monday, January 3, Veridex announced  the start of a collaboration with Massachusetts General Hospital to develop a next-generation, automated diagnostic  test sensitive enough to detect a stray cancer cell among a billion blood cells and powerful enough to reveal the biology of cells at the DNA, RNA and protein levels – all from a non-invasive blood test. 

As we said in our press releasethe collaboration, which involves Ortho Biotech Oncology R&D , Unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., aims to develop a system  that could be used both by oncologists as a diagnostic tool for personalizing patient care, as well as by researchers to accelerate and improve the process of drug discovery and development.  

At Johnson & Johnson, our multidisciplinary business model already brings together the internal capabilities of our diagnostics business and our pharmaceutical sector to drive innovation. Adding the scientific and clinical expertise of Massachusetts General Hospital makes this a unique and powerful opportunity to advance the field of diagnostics.

We’re excited about this collaboration — and about the interest in this news!  The story has spread far and wide through the media as reporters talk, write (and tweet!) about the announcement.  

There has been some confusion in some of the media stories, however, between the technology that this collaboration will focus on and existing technology that Massachusetts General Hospital developed previously.   Veridex and Massachusetts General Hospital will work together to develop a novel magnetic-based bench-top system that aims for higher sensitivity than current technology, as well as suitability for broad applications and ready dissemination.  Separately, the Massachusetts General Hospital team has developed first and second-generation versions of a microfluidic chip capable of capturing these cells with a high rate of efficiency.  This chip is not associated with the collaboration we announced on January 3. 

Although this is just the beginning of this collaboration and there is much work to do, we are proud to be part of this important step forward in the field of oncology and look forward to the benefits that this technology could one day bring to researchers, doctors, and ultimately, patients.

Read More

January 4th, 2011

Happy New Year!

It’s a new year, and you know what that means.  It’s time to get to work on those resolutions, whether you’re planning to go to the gym more often (like me) or eat healthier foods.  In honor of the new year, the Johnson & Johnson Health Channel is featuring a couple of videos highlighting different physical activities.  Check out Anna and Tobin as they talk about what they do to stay healthy.

Need further motivation to be active this year?  Read this Kilmer House post on our athletic employees to learn about the early organized sports teams at J&J.  Whether it’s joining a bowling team like our own General Robert Wood Johnson or just taking a walk around the block, stay healthy and happy in 2011.

Read More

December 22nd, 2010

Tips For Avoiding “PDA Pain” During The Holiday Season

From Susan Tierman, Director, Occupational Medicine, Johnson & Johnson

During this busy holiday season, many employees throughout the Johnson & Johnson Family of Companies take their work out of the office and into their own hands—literally. The use of modern connectivity devices such as PDAs, smart phones and other mobile devices allow employees at any company to easily stay connected to work commitments when away from their desk. While this offers the flexibility to work remotely, employees should be careful that this added connectivity does not interfere with spending quality time with family and friends. Additionally, with the increase in mobile emailing and typing on tiny keyboards comes a health concern many people have yet to consider…“PDA Pain.”

“PDA Pain” is a form of repetitive stress injury (RSI) caused by overusing the thumb, or thumbs, and straining the digit through continuous pressing on the mobile device keyboard. While most people use their thumb(s) to type texts or emails, the thumb does not have as much dexterity as its longer and leaner counterparts. In fact, the thumb was designed more so as a “pinch and grip” stabilizer (think about how you press your thumb and index finger together to pick up a pen) than a typing tool.

Read More

December 15th, 2010

Today’s Organizational Announcements

Earlier today, we issued a press release announcing that Alex Gorsky, currently Worldwide Chairman, Medical Devices & Diagnostics and Sheri McCoy, currently Worldwide Chairman, Pharmaceuticals, have been appointed Vice Chairmen of the Executive Committee and join William C. Weldon, Chairman of the Board and Chief Executive Officer, in an expanded Office of the Chairman. Both appointments are effective January 3, 2011. In the communication distributed globally to all Johnson & Johnson employees, Bill summed up these organizational changes in the following way:

As the Johnson & Johnson Family of Companies continues to grow and we look toward opportunities and challenges of the future, it is important for us to regularly assess our organizations to ensure that they remain focused strategically, resourced properly and structured appropriately.

Today I am announcing organizational realignments within our leadership team that are being taken to ensure that we continue to be well positioned for sustainable growth into the future. Our organizational changes are an appropriate step in furthering our long-term succession plans within Johnson & Johnson, assuring talented, experienced leaders at all levels of the organization. The changes remain consistent with our philosophy of decentralization and are designed to improve Johnson & Johnson’s capacity to grow and to provide a platform for effective and efficient operations.

Read More

December 14th, 2010

Who Will be the Next Winner of the Dr. Paul Janssen Award for Biomedical Research?

By Paul Stoffels, Global Head, Pharmaceuticals Research & Development, Johnson & Johnson

This morning, the 2011 Dr. Paul Janssen Award for Biomedical Research call for nominations officially opened. Once again, Johnson & Johnson will recognize a scientist or group of scientists, selected by an independent committee, whose achievements in the field of biomedicine or medical technology have made, or have strong potential to make, a measurable impact on human health.

Over just six years, the Award has accumulated a truly remarkable roster of winners whose transformative work has impacted millions of lives. By recognizing their accomplishments, we keep alive the spirit of Dr. Paul Janssen, for whom the Award is named, and encourage the next generation of innovative researchers.

I’ve had the privilege to meet the previous Award winners, many of whom have made discoveries that have had a profound impact on human health. For example, it was truly my honor to recognize our 2010 Award winners, Dr. Anthony Fauci and Dr. Erik De Clercq, whose work in HIV/AIDS has transformed the treatment landscape. Having worked myself side-by-side with Dr. Paul in this therapeutic area, I know this work was close to his heart and I know the achievements of our winners would have been greatly appreciated by Dr.

Read More

December 9th, 2010

Smart Moves, Smart Choices

From Jeff Christensen, Manager, Product Communication, Johnson & Johnson Pharmaceutical Services, supporting PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Surrounded by high school students, teachers, school nurses and parents, I sat riveted to my seat in an L.A. auditorium last month as I listened to addiction expert and national TV host Dr. Drew Pinsky give a chilling warning on the subject of teenagers abusing prescription medications:

The scariest thing I ever hear a parent say are the following words:  “Not my kid…My kid’s a student athlete…My kid’s an honor student…My kid’s a good kid.”  It can happen to anybody–anybody’s kid!  So, number one, never say, “Not my kid.

It was sobering advice for anyone, but especially for those of us who are parents.  Dr. Drew—as his viewers know him—is a board-certified specialist in addiction medicine who delivers a moving speech.  On this day we were taping a town-hall style meeting with him for Smart Moves, Smart Choices, a program which aims to educate students, parents and educators about the prevalence and serious risks of teenage prescription drug abuse.  The National Association of School Nurses (NASN) and PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., partnered to develop Smart Moves, Smart Choices.  PriCara also sponsors the program.

Read More

December 8th, 2010

Celebrating Arts + Health Month

From Ashley Atkins, Ph.D., Art Administrator, Corporate Contributions, Johnson & Johnson

November marked the first annual Arts + Health Month, promoted by the Society for the Arts in Healthcare.  The Society designated November as a time “for organizations and individuals worldwide to promote the integration of the arts—including literary, performing, and visual arts and design—into a wide variety of healthcare and community settings for therapeutic, educational, and expressive purposes.” A quick glance through the calendar of events shows an impressive number of conferences, exhibitions, performances, and other events that occurred throughout the world, all of which promoted the positive impact that the arts can have on health and wellness. 

For me, the month provided an opportunity to think about the impact that our Company’s partnership with the Society has been able to achieve in the past 10 years.  Since 2001, Johnson & Johnson and the Society have provided funds to 117 programs through the United States and Canada, all of which have used the arts to create positive impacts on patients, caregivers and healthcare professionals by incorporating the arts and design into the healthcare setting and environment.  It has been inspiring to see these programs and the field of arts and healthcare grow from creating innovative art displays and healing gardens in hospital environments to programs like Snow City Arts, which provides hospitalized children the opportunity to earn school credit through arts programs. 

I also had the privilege this month of visiting two organizations that have been the recipients of our partnership grant.

Read More

December 2nd, 2010

The Wrath of Winter…Staying Safe this Season

From Lindsay Hansen, Program Manager – Recreational Safety, Safe Kids USA

Fall sports have wrapped up and the winter sports season is upon us.  As we all know, once the air gets colder and snow starts falling, kids head outside to the great outdoors to ski, snowboard, sled, snowmobile and ice skate.  While these winter activities provide hours of fun for our children, they also pose risks for injury.

I should note that JNJ BTW has posted before on youth sports injury; Andrew gave tips on preventing sports injury and Dr. Freishtat offered advice on communicating effectively with your children and their coaches.  That information should be kept in mind all year round, but here are winter sports specific tips to remember as well.

Safe Kids USA reports that about 250,000 people experience injuries while engaging in winter sports activities.  More than one-fifth of these emergency room visits are from children 14 and under.  For parents and kids to get the most enjoyment out of the winter sports season, it is important to remember some key safety tips.

  • Wear a sport-specific helmet!
  • Dress in layers and wear warm, close-fitting clothes.
  • Wear sunscreen with an SPF of 15 or higher.
  • Wear sunglasses and contacts with UV protection.

Read More